Search for other papers by Samer El-Kaissi in
Google Scholar
PubMed
Search for other papers by Laila AbdelWareth in
Google Scholar
PubMed
Search for other papers by Ruba Dajani in
Google Scholar
PubMed
Search for other papers by Terrence J. Lee-St. John in
Google Scholar
PubMed
Search for other papers by Sherry Ann Santarina in
Google Scholar
PubMed
Search for other papers by Fiona Makia in
Google Scholar
PubMed
Search for other papers by Malak AlTakruri in
Google Scholar
PubMed
Search for other papers by AbedElRahman Kaskas in
Google Scholar
PubMed
Search for other papers by Yahya Ahmed in
Google Scholar
PubMed
plasma TSH (mIU/L) pre- and post-Ramadan modeled using mixed-effects regression for baseline TSH at 25th, 50th, and 75th percentiles. Reference range for plasma TSH 0.27–4.20 mIU/L. TSH increased in all 3 groups for patients at the 25th percentile
Search for other papers by Omar Abdul Hameed Ali in
Google Scholar
PubMed
Search for other papers by Abdul Fatah Abdul Gadir in
Google Scholar
PubMed
, the long-term influence of a different iodine intake results in considerable differences in thyroid volume as early as in childhood. By adolescence, the volume approaches what might be defined as normal thyroid. In Sudan the reference range of thyroid
Search for other papers by Toshihide Yamamoto in
Google Scholar
PubMed
were measured 3 months after dosage adjustment. Doses to keep serum TSH levels within the reference range were maintained. All of them had stayed in a euthyroid state and had never been treated with medication containing glucocorticoids (GC). Seven
Search for other papers by Luba Freja Michaelsson in
Google Scholar
PubMed
Search for other papers by Bjarke Borregaard Medici in
Google Scholar
PubMed
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jeppe Lerche la Cour in
Google Scholar
PubMed
Search for other papers by Christian Selmer in
Google Scholar
PubMed
Division of Pharmacies and Reimbursement, Danish Health and Medicines Authority, Copenhagen, Denmark
Search for other papers by Michael Røder in
Google Scholar
PubMed
Search for other papers by Hans Perrild in
Google Scholar
PubMed
Search for other papers by Nils Knudsen in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
, 14% of respondents reported that their TSH level was less than 0.01 mU/l (totally suppressed). The TSH level at the time of diagnosis of hypothyroidism was reported being below 4 mU/l in 26%, i.e. below the recommended upper normal reference range in
Search for other papers by Annamaria Erdei in
Google Scholar
PubMed
Search for other papers by Annamaria Gazdag in
Google Scholar
PubMed
Search for other papers by Bernadett Ujhelyi in
Google Scholar
PubMed
Search for other papers by Edit B Nagy in
Google Scholar
PubMed
Search for other papers by Ervin Berenyi in
Google Scholar
PubMed
Search for other papers by Eszter Berta in
Google Scholar
PubMed
Search for other papers by Zita Steiber in
Google Scholar
PubMed
Search for other papers by Sandor Barna in
Google Scholar
PubMed
Search for other papers by Emese Mezosi in
Google Scholar
PubMed
Search for other papers by Miklos Bodor in
Google Scholar
PubMed
Search for other papers by Endre V Nagy in
Google Scholar
PubMed
exophthalmos and symmetric periorbital edema were seen. Low thyroid-stimulating hormone (TSH) (0.006 mU/L, reference range: 0.3-4.2 mU/L) was accompanied by normal free thyroxine and free triiodothyronine levels and elevated TSH receptor antibodies (TRAb: 10
Search for other papers by Maja Hjelm Lundgaard in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Search for other papers by Ulla Birgitte Christiansen in
Google Scholar
PubMed
Department of Gynaecology and Obstetrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Anne Sørensen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Søren Risom Kristensen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
diagnosis of hypothyroidism was made, treatment with levothyroxine (50 µg per day) was unaltered. Biochemical assessment revealed improvement in patient thyroid function and TSH as well as T4 and T3 were within the reference ranges at 6 months follow
Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by J Karmisholt in
Google Scholar
PubMed
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by S L Andersen in
Google Scholar
PubMed
Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by I Bulow-Pedersen in
Google Scholar
PubMed
Search for other papers by A Krejbjerg in
Google Scholar
PubMed
Search for other papers by B Nygaard in
Google Scholar
PubMed
Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by A Carlé in
Google Scholar
PubMed
, agranulocytosis, and liver failure. Thyroid hormone and antibody assays Serum total T3 (reference range: Aalborg 1.1–2.5 nmol/L, Copenhagen 1.0–2.6 nmol/L), and TSH (reference range: Aalborg 0.30–4.5mU/L, Copenhagen 0.40–4.0 mU/L) were measured by automatic
Search for other papers by Marta Amaro da Silveira Duval in
Google Scholar
PubMed
Search for other papers by André Borsatto Zanella in
Google Scholar
PubMed
Search for other papers by Ana Patrícia Cristo in
Google Scholar
PubMed
Search for other papers by Carlo Sasso Faccin in
Google Scholar
PubMed
Search for other papers by Marcia Silva Graudenz in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
consent. Laboratory Measurements TSH levels were measured by electrochemiluminescence immunoassay (ADVIA Centaur XP; Siemens, Tarrytown, NY, USA), with a reference range of 0.4–4.2 mIU/L. sTg and FNA-Tg were measured by chemiluminescence (ECLIA
Department of Pediatric Endocrinology, Faculty of Medicine, Istinye University, Istanbul, Turkey
Search for other papers by Cengiz Kara in
Google Scholar
PubMed
Search for other papers by Jamala Mammadova in
Google Scholar
PubMed
Department of Medical Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
Search for other papers by Ümmet Abur in
Google Scholar
PubMed
Department of Medical Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
Search for other papers by Cagri Gumuskaptan in
Google Scholar
PubMed
Search for other papers by Elif İzci Güllü in
Google Scholar
PubMed
Search for other papers by Ayhan Dağdemir in
Google Scholar
PubMed
Search for other papers by Murat Aydın in
Google Scholar
PubMed
and free thyroxine (FT4) measurements, according to laboratory reference values (see supplementary material for reference ranges). All CH patients with low serum FT4 and/or persistently high (>10 µU/mL) TSH were treated with l -thyroxine (LT4). Two
Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea
Search for other papers by Chae Won Chung in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Kyungsik Kim in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Sue K Park in
Google Scholar
PubMed
Search for other papers by Dal Lae Ju in
Google Scholar
PubMed
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
Search for other papers by Young Joo Park in
Google Scholar
PubMed
Search for other papers by Choong Ho Shin in
Google Scholar
PubMed
Search for other papers by Jong Kwan Jun in
Google Scholar
PubMed
Search for other papers by June-Key Chung in
Google Scholar
PubMed
Search for other papers by Yoon Ju Song in
Google Scholar
PubMed
Search for other papers by Young Ah Lee in
Google Scholar
PubMed
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Gi Jeong Cheon in
Google Scholar
PubMed
Search for other papers by Sun Wook Cho in
Google Scholar
PubMed
, Korea; free T3 and anti-TPO Ab, BRAHMS, Germany). The reference range, detection limit, intra-assay, and inter-assay CV were as follows: TSH (reference range: 0.30–5.00 mIU/L; detection limit: 0.02 mIU/L; intra-assay CV (%): 5.60/4.84/6.12; inter